Skip to main content
Premium Trial:

Request an Annual Quote

Protein Biochips Market May Reach $430 Million By 2007

NEW YORK, Aug 6 (GenomeWeb News) - The protein biochip systems market was worth $170 million last year, and may eventually reach $430 million by 2007, the Bioperspectives pharmaceutical consulting company said last week.

 

Biochip technologies including DNA chip systems and protein chips are seen as the next logical step forward in the research and development of drugs, the report said.

 

Though protein biochips systems are growing quickly, they still lag behind DNA chips systems in the market, which were estimated to be worth $1 billion last year.

 

It is well known that genomic and proteomic chip technologies have been enormously successful in finding changes in expression between genes and proteins in normal and diseased states. The report, however, identified protein biochips as a key technology in determining if changes in proteins correlate with disease states and/or treatments.

 

Read an interview with the report's author, Steven Bodovitz, in the Aug. 13 issue of ProteoMonitor.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.